Cetera Investment Advisers Ocular Therapeutix, Inc Transaction History

Cetera Investment Advisers

  • $49.2 Billion
  • Q1 2025

A detailed history of Cetera Investment Advisers transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 721,364 shares of OCUL stock, worth $5.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
721,364
Previous 723,840 0.34%
Holding current value
$5.69 Million
Previous $6.18 Million 14.46%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025
SELL
$5.93 - $9.08 $14,682 - $22,482
-2,476 Reduced 0.34%
721,364 $5.29 Million
Q4 2024

Feb 13, 2025
BUY
$8.33 - $11.47 $36,168 - $49,802
4,342 Added 0.6%
723,840 $6.18 Million
Q3 2024

Nov 13, 2024
SELL
$6.45 - $9.23 $126,071 - $180,409
-19,546 Reduced 2.64%
719,498 $6.26 Million
Q2 2024

Aug 22, 2024
BUY
$4.2 - $8.69 $54,826 - $113,439
13,054 Added 1.8%
739,044 $5.06 Million
Q1 2024

May 24, 2024
BUY
$3.85 - $10.93 $2.8 Million - $7.94 Million
725,990 New
725,990 $6.61 Million
Q4 2023

Feb 13, 2024
BUY
$2.08 - $4.52 $137,904 - $299,676
66,300 Added 10.87%
676,400 $3.02 Million
Q3 2023

Nov 14, 2023
SELL
$3.14 - $5.04 $3,611 - $5,796
-1,150 Reduced 0.19%
610,100 $1.92 Million
Q2 2023

Aug 09, 2023
BUY
$4.6 - $7.64 $46,460 - $77,164
10,100 Added 1.68%
611,250 $3.15 Million
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $16,600 - $37,306
5,950 Added 1.0%
601,150 $3.17 Million
Q4 2022

Feb 14, 2023
SELL
$2.61 - $4.41 $24,403 - $41,233
-9,350 Reduced 1.55%
595,200 $1.67 Million
Q3 2022

Nov 10, 2022
BUY
$4.09 - $6.5 $22,086 - $35,100
5,400 Added 0.9%
604,550 $2.51 Million
Q2 2022

Aug 11, 2022
BUY
$3.01 - $5.22 $97,524 - $169,128
32,400 Added 5.72%
599,150 $2.41 Million
Q1 2022

May 13, 2022
BUY
$4.83 - $7.35 $284,970 - $433,650
59,000 Added 11.62%
566,750 $2.81 Million
Q4 2021

Feb 14, 2022
BUY
$6.16 - $12.07 $466,004 - $913,095
75,650 Added 17.51%
507,750 $3.54 Million
Q3 2021

Nov 16, 2021
BUY
$9.7 - $14.34 $4.19 Million - $6.2 Million
432,100 New
432,100 $4.32 Million

Others Institutions Holding OCUL

# of Institutions
207
Shares Held
135M
Call Options Held
426K
Put Options Held
119K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $607M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email